Michael Brammer launched FamGenix in 2019, a platform designed to allow patients to record and manage their family health histories and ultimately share this data with healthcare providers. The platform consists of an App patients can download for both iPhone and Android devices for free, and a clinician portal for healthcare providers. The FamGenix App will identify patients who are at an increased risk of hereditary cancers and meet referral criteria for genetic counseling based on NCCN and ACMG guidelines. In 1996, Brammer co-founded Progeny Software. As CEO, he guided the company to accumulating over 2000 customers in more than 80 countries, providing software tools to assist researchers and clinicians in gathering and managing family health histories. In 2015, Brammer sold the company to Ambry Genetics and as CEO, spent 2 years transitioning operations over to them.
Health Monitoring Showcase:
FamHis, Inc. is the developer of the FamGenix platform, where patients record and manage their family health histories.
Precision Medicine begins with Family Health Histories
One of the most accurate predictors of a person’s overall risks of developing a disease is their family health history. FamGenix is a platform built based on feedback from researchers and clinicians worldwide striving to accurately record family health histories.
The PMWC 2020 Health Monitoring Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in remote patient and care monitoring, providing devices that are smart and integrated with high-touch approaches, sensors, data collection and analytical capabilities translating patient vital signs into useful insights and alert triggers. These companies will share their innovative products to an audience of leading investors, potential clients, and partners. The PMWC 2019 Health Monitoring Showcase will exhibit the latest innovations that lead to products, systems, and services that empower patients with chronic conditions to better understand and self-manage their conditions and provide clinicians with easy, efficient monitoring that enhance patients’ lives and enable the delivery of better outcomes at lower cost.